title: Embryo gene expression in response to maternal supplementation with glycogenic precursors in the rabbit.
abstract: Disturbing maternal metabolism during the first pregnancy and postpartum period is associated with sub fertility in rabbit does. Nutritional strategies can be used during those periods and its effects to improve reproductive management may affect periconceptional events and early embryo development. Our goal was to elucidate if treatment with a glycogenic precursor such as propylene glycol (PG) could affect the maternal metabolic profile, follicular and oocyte quality and gene expression patterns in early embryos. Rabbit does were supplemented with 2.5% (v/v) PG from either mid-pregnancy and for 25 days of lactation (PG-GL group); only during lactation (PG-L group); or were not treated (control group). Ovarian parameters and embryos were studied at the end of treatment. At parturition serum non-esterified fatty acid concentrations increased whilst insulin decreased in all groups. Maternal feed intake was reduced in PG-supplemented does but glycaemia was maintained during the experimental period. When PG was suppressed, blood insulin immediately increased in PG-groups, but no differences in follicular population, follicular atresia, and nuclear and cytoplasmic oocyte maturation were observed compared with non-treated animals. Although embryo development was similar among groups, mRNA of SLC2A4, INSR, IGF1R, PLAC8, COX2 and IGF2R were up regulated in the blastocysts of PG-GL does. Transcripts of SOD1 were lower in PG-L embryos; but NOS3 and TP53 were similar among groups. PG did not affect the maternal metabolic profile during the postpartum period, nor the ovarian response or number of embryos developed. Nonetheless, PG supplied from mid-pregnancy modified mRNA transcripts involved in some important developmental and metabolic events in the blastocysts of those females. More experiments are needed to elucidate the physiological consequence of these results.
authors.forename: M
authors.initials: M
authors.lastname: Arias-Álvarez
authors.forename: R M
authors.initials: RM
authors.lastname: García-García
authors.forename: P L
authors.initials: PL
authors.lastname: Lorenzo
authors.forename: A
authors.initials: A
authors.lastname: Gutiérrez-Adán
authors.forename: O G
authors.initials: OG
authors.lastname: Sakr
authors.forename: A
authors.initials: A
authors.lastname: González-Bulnes
authors.forename: P G
authors.initials: PG
authors.lastname: Rebollar
mesh_terms: D000821:Animal Feed; D000818:Animals; D019587:Dietary Supplements; D047108:Embryonic Development / Q000187:drug effects* / Q000235:genetics*; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006003:Glycogen / Q000008:administration & dosage* / Q000378:metabolism; D007774:Lactation / Q000187:drug effects / Q000378:metabolism; D039382:Maternal Nutritional Physiological Phenomena / Q000187:drug effects*; D036801:Parturition / Q000187:drug effects / Q000378:metabolism; D049590:Postpartum Period / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal; D011355:Prodrugs / Q000008:administration & dosage*; D011817:Rabbits
chemical_list: D011355:Prodrugs; D006003:Glycogen